Chemotherapy-Induced Neutropenia/Febrile Neutropenia Prophylaxis with Biosimilar Filgrastim in Solid Tumors Versus Hematological Malignancies: MONITOR-GCSF Study

Heinz Ludwig1 Medizinische Abteilung I – Onkologie und Haematologie, Wilhelminenspital, Wienpäoh, Montleartstraße 37, 1160Vienna, Austria

Carsten Bokemeyer2 Department of Oncology, Hematology&BMT with Section of Pneumology Universitaetsklinikum Hamburg Eppendorf, Martinistraße 52, 20246Hamburg, Germany

Matti Aapro3 Cancer Center, Clinique de Genolier, Route du Muids 3, 1272Genolier, Switzerland

Mario Boccadoro4 Dipartimento di Oncologia e Ematologia, Azienda Ospedaliero Universitaria S Giovanni Battista di Torino, Via Cherasco 15, 10126Torino, Italy

Pere Gascón5 Department of Hematology–Oncology, Division of Medical Oncology, Hospital Clínic de Barcelona, University of Barcelona, Carrer de Villarroel 170, 08036Barcelona, Spain

Kris Denhaerynck6 Matrix45, Tucson, 6159 West Sunset Road, Tucson, AZ85743, USA;7 Department of Public Health, University of Basel, Bernoullistrasse 28, 4056Basel, Switzerland

Andriy Krendyukov8 Hematology and Oncology, Hexal AG, Industriestraße 25, 83607Holzkirchen, Germany (formerly)

Ivo Abraham6 Matrix45, Tucson, 6159 West Sunset Road, Tucson, AZ85743, USA;9 Department of Pharmacy Practice&Science, College of Pharmacy, University of Arizona, Tucson, AZ85721, USA;10 Center for Health Outcomes&PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA;11 Department of Family&Community Medicine, College of Medicine, University of Arizona, Tucson, AZ85724, USACorrespondence[email protected]

Karen MacDonald6 Matrix45, Tucson, 6159 West Sunset Road, Tucson, AZ85743, USA

show all

Chemotherapy-Induced Neutropenia/Febrile Neutropenia Prophylaxis with Biosimilar Filgrastim in Solid Tumors Versus Hematological Malignancies: MONITOR-GCSF Study

Supplemental Table 1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Chemotherapy-Induced Neutropenia/Febrile Neutropenia Prophylaxis with Biosimilar Filgrastim in Solid Tumors Versus Hematological Malignancies: MONITOR-GCSF Study

Supplemental Table 1

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date